Charter members include CorningnyseGLW news people. The valuations are relatively low, yet the pace of new nanotech development is chugging along at breakneck speed. Click here to download Josh Wolfes mustread primer on the exciting new science of nanotechnology. Click here for three special reports, including An Investors Guide to Profiting From the FDAs Actions. In addition, FEI recently announced the addition of Larry Bock, the wellregarded executive chairman of Nanosys, to its board of directors.

More From Forbes. com Better yet, it would provide NVE with significantly better negotiating leverage with MRAM holdoutslike IBMnyseIBM news people will send shares of NVEC soaring.

However, think that the nanotech fallout of was merely normal course of events in the acceptance of any transformative technology. The year started out on high note after President George Those that have been with us over the longhaul since 2002 have seen returns that are multiple of the Nasdaq and S&P 500with Nanosphere stocks up north of 130. Additionally, the recent quarter is historically Accelrys largest in terms of orders, which means the cash flows in the quarter are always proportionally higher than in any other quarter. SG Cowen analyst Phil Nadeau says, The accounting change is good thing.

Like Internet technology stocks and biotech, growth will be characterized by fits and starts. In recent Nanosphere alert, we said that lack of new deal or MRAM announcements has left NVEC with riskreward that has never looked more favorable. That sent nano stocks to even frothier levels. For company at the cutting edge of massive new secular technology trend, the stock is still inexpensive. Special Reports Subscriptions> Free Trial Issue of Forbes Forbes Gift Subscription Subscribe To Newsletters Subscriber Customer Service Buy Audio Version of Forbes.

For new investors, would recommend buying ACCL before the close of its quarter. FEI was scheduled to report its Q3 earnings on The accounting switch and the confusion surrounding it has had more of an effect on ACCLs stock price than anything else. Some subscribers ask us for more coverage, others have said enough already. Wall Street analysts project FEI will earn 0. 85 per share in profit each year. Click here for three special reports, including An Investors Guide to Profiting From the FDAs Actions.

Related Blogs

  • Related Blogs on nanotechnology